|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-8-19
|
|
pubmed:abstractText |
To determine whether the new fluoroquinolone prulifloxacin might improve tolerance to Bacillus Calmette-Guérin (BCG) intravesical therapy in patients with bladder cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
633-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19298412-Administration, Intravesical,
pubmed-meshheading:19298412-Anti-Bacterial Agents,
pubmed-meshheading:19298412-BCG Vaccine,
pubmed-meshheading:19298412-Dioxolanes,
pubmed-meshheading:19298412-Drug Therapy, Combination,
pubmed-meshheading:19298412-Drug Toxicity,
pubmed-meshheading:19298412-Epidemiologic Methods,
pubmed-meshheading:19298412-Female,
pubmed-meshheading:19298412-Fluoroquinolones,
pubmed-meshheading:19298412-Humans,
pubmed-meshheading:19298412-Male,
pubmed-meshheading:19298412-Middle Aged,
pubmed-meshheading:19298412-Neoplasm Invasiveness,
pubmed-meshheading:19298412-Piperazines,
pubmed-meshheading:19298412-Treatment Outcome,
pubmed-meshheading:19298412-Urinary Bladder Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer: an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?
|
|
pubmed:affiliation |
UOC Urologia, Università Magna Greacia, Catanzaro, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
